Musaffa Logo

Our certifications

Independent proof that every stock and portfolio meets halal standards.

How we screen every stock
METHODOLOGY

How we screen every stock

Our 5-step halal methodology, in 90 seconds.

OBIO Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: June 08, 2026

Report Source: 2026 1st Quarter Report

Analyst's Ratings for Orchestra Biomed Holdings Inc (OBIO)

Based on 14 analysts giving stock ratings to Orchestra Biomed Holdings Inc in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
21
Buy
65
Hold
14
Sell
0
Strong Sell
0
Orchestra Biomed Holdings Inc

Orchestra Biomed Holdings Inc. Stock Analysis OBIO

United States Health Care Micro Cap Report:
Orchestra Biomed Holdings, Inc. engages in the provision of biomedical technologies to patients through risk-reward-sharing partnerships with medical device companies. The company is headquartered in New Hope, Pennsylvania and currently employs 86 full-time employees. The company went IPO on 2020-08-04. The Company’s lead product candidates include Atrioventricular Interval Modulation (AVIM) therapy for the treatment of hypertension (HTN), the leading risk factor for death worldwide and the Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the leading cause of mortality worldwide. The firm develops bioelectronic therapies based on patented Cardiac Neuromodulation Therapy (CNT) technology. The AVIM is a bioelectronic therapy candidate designed to substantially and persistently lower blood pressure. Its Virtue SAB is a proprietary drug/device combination product candidate for the treatment of artery disease that is designed to deliver a proprietary, investigational, extended-release formulation of sirolimus (SirolimusEFR) to the vessel wall during balloon angioplasty without the need for balloon coating or a permanent implant.
Read More

Orchestra Biomed Holdings Inc (OBIO) Chart

Key Statistics of Orchestra Biomed Holdings Inc (OBIO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$3.94$4.12

Today's Open

$4.02

Volume

97.59K

P/E Ratio (TTM)

-

52 Week Range

$2.20$5.42

Market Cap

245.51M

Avg. Volume

234.68K

Dividend Yield

-

Financial Metrics & Statements of Orchestra Biomed Holdings Inc (OBIO)

FAQ's for Orchestra Biomed Holdings Inc (OBIO)

  • According to Musaffa’s Shariah screening methodology, Orchestra Biomed Holdings Inc (OBIO) is currently classified as NOT HALAL as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Orchestra Biomed Holdings Inc using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Orchestra Biomed Holdings Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Orchestra Biomed Holdings Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Orchestra Biomed Holdings Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Orchestra Biomed Holdings Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.